Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Pollack

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Sarcoma|February 19, 2011
Immune-based therapies for sarcomaSeth M Pollack, Elizabeth T Loggers, Eve T Rodler, et al.
Future Oncology (London, England)|January 31, 2017
Novel therapeutic approaches in chondrosarcomaGenovefa Polychronidou, Vasilios Karavasilis, Seth M Pollack, et al.
Medical Oncology (Northwood, London, England)|March 5, 2013
Clinical benefit of trabectedin in uterine adenosarcomaBrett A Schroeder, Eve T Rodler, Elizabeth T Loggers, et al.
Rare Tumors|February 2, 2013
Systemic therapy in primary angiosarcoma of the spleenBruna Pellini Ferreira, Eve T Rodler, Elizabeth T Loggers, et al.
Medical Oncology (Northwood, London, England)|August 31, 2017
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcomaRobin L Jones, Daniela Katz, Elizabeth T Loggers, et al.
Current Opinion in Oncology|July 15, 2022
Immunotherapy of sarcomas with modified T cellsPreethika Mahalingam, Maximilian Julve, Paul Huang, et al.
Rare Tumors|February 14, 2017
The Imaging and Pathological Features of Metastatic Leiomyosarcoma in the GallbladderYi Guo, Eleanor Chen, Darin J Davidson, et al.
Cancer Treatment Reviews|February 19, 2025
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapyGabrielle Knafler, Alan L Ho, Kathleen N Moore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantationSeth M Pollack, Seth M Steinberg, Jeanne Odom, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Response to PD1 inhibition in conventional chondrosarcomaMichael J Wagner, Robert W Ricciotti, Jose Mantilla, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Sarcoma|February 19, 2011
Immune-based therapies for sarcomaSeth M Pollack, Elizabeth T Loggers, Eve T Rodler, et al.
Future Oncology (London, England)|January 31, 2017
Novel therapeutic approaches in chondrosarcomaGenovefa Polychronidou, Vasilios Karavasilis, Seth M Pollack, et al.
Medical Oncology (Northwood, London, England)|March 5, 2013
Clinical benefit of trabectedin in uterine adenosarcomaBrett A Schroeder, Eve T Rodler, Elizabeth T Loggers, et al.
Rare Tumors|February 2, 2013
Systemic therapy in primary angiosarcoma of the spleenBruna Pellini Ferreira, Eve T Rodler, Elizabeth T Loggers, et al.
Medical Oncology (Northwood, London, England)|August 31, 2017
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcomaRobin L Jones, Daniela Katz, Elizabeth T Loggers, et al.
Current Opinion in Oncology|July 15, 2022
Immunotherapy of sarcomas with modified T cellsPreethika Mahalingam, Maximilian Julve, Paul Huang, et al.
Rare Tumors|February 14, 2017
The Imaging and Pathological Features of Metastatic Leiomyosarcoma in the GallbladderYi Guo, Eleanor Chen, Darin J Davidson, et al.
Cancer Treatment Reviews|February 19, 2025
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapyGabrielle Knafler, Alan L Ho, Kathleen N Moore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantationSeth M Pollack, Seth M Steinberg, Jeanne Odom, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Response to PD1 inhibition in conventional chondrosarcomaMichael J Wagner, Robert W Ricciotti, Jose Mantilla, et al.
Pageof 11